Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited (RDY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RDY · as of Jun 8, 2026
Key Statistics
Explore Dr. Reddy's Laboratories Limited Data
rdy stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 50.0%
Competitors & Peers
rdy competitorsRDY
BMRN
EHC
ELAN
ENSG
EXELStock Performance
Full HistoryAbout Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active In…
what is dr. reddy's laboratories limited · rdy stock overview · dr. reddy's laboratories limited company profile · who is dr. reddy's laboratories limited ceo · rdy NYSE · dr. reddy's laboratories limited headquarters · dr. reddy's laboratories limited business segments
About Stock Overview & Key Data
Dr. Reddy's Laboratories Limited (RDY) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NYSE since Apr 11, 2001. As of the latest trading session, RDY stock price is $13.24, with a market capitalization of $11.0B. The stock has returned -15.29% over the past 12 months and -5.70% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Dr. Reddy's Laboratories Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2026, Dr. Reddy's Laboratories Limited reported revenue of $353.5B and net income of $45.1B. For detailed data — including Dr. Reddy's Laboratories Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Dr. Reddy's Laboratories Limited (RDY) stock price is $13.24. The stock is traded on NYSE under the ticker symbol RDY. The 52-week range is $12.19 – $16.17.